ImmuPharma (LON:IMM) Trading Up 23.8% – What’s Next?

Shares of ImmuPharma plc (LON:IMMGet Free Report) rose 23.8% during mid-day trading on Saturday . The company traded as high as GBX 5.70 ($0.07) and last traded at GBX 4.83 ($0.06). Approximately 16,731,404 shares traded hands during mid-day trading, a decline of 23% from the average daily volume of 21,725,510 shares. The stock had previously closed at GBX 3.90 ($0.05).

ImmuPharma Stock Performance

The stock’s fifty day moving average price is GBX 2.46 and its 200-day moving average price is GBX 1.95. The company has a market capitalization of £20.11 million, a P/E ratio of -483.00 and a beta of 1.53.

About ImmuPharma

(Get Free Report)

ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.

Featured Articles

Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.